Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer

Technology appraisal guidance
Reference number: TA192
Published: 28 July 2010

Lung cancer (non-small-cell, first line) - gefitinib: appendix A - GE decision paper - December 2014

Lung cancer (non-small-cell, first line) - gefitinib: appendix A - GE decision paper - December 2014

Lung cancer (non-small-cell, first line) - gefitinib: appendix A - GE decision paper - December 2014
15 December 2014
(495.7 Kb 24 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 12 December 2014